(S)-8-氯-1-甲基-2,3,4,5-四氢-1H-3-苯并氮杂卓
更新时间：2025-11-30 06:52:09
(S)-8-氯-1-甲基-2,3,4,5-四氢-1H-3-苯并氮杂卓结构式
|
常用名 | (S)-8-氯-1-甲基-2,3,4,5-四氢-1H-3-苯并氮杂卓 | 英文名 | 1H-3-Benzazepine, 8-chloro-2,3,4,5-tetrahydro-1-Methyl-, (1S)- |
|---|---|---|---|---|
| CAS号 | 616202-81-4 | 分子量 | 195.689 | |
| 密度 | 1.1±0.1 g/cm3 | 沸点 | 288.1±40.0 °C at 760 mmHg | |
| 分子式 | C11H14ClN | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 128.1±27.3 °C |
| 中文名 | 绿卡色林中间体-7 |
|---|---|
| 英文名 | (5S)-7-chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| 英文别名 | 更多 |
| 密度 | 1.1±0.1 g/cm3 |
|---|---|
| 沸点 | 288.1±40.0 °C at 760 mmHg |
| 分子式 | C11H14ClN |
| 分子量 | 195.689 |
| 闪点 | 128.1±27.3 °C |
| 精确质量 | 195.081482 |
| PSA | 12.03000 |
| LogP | 2.89 |
| InChIKey | XTTZERNUQAFMOF-MRVPVSSYSA-N |
| SMILES | CC1CNCCc2ccc(Cl)cc21 |
| 蒸汽压 | 0.0±0.6 mmHg at 25°C |
| 折射率 | 1.527 |
|
~97%
(S)-8-氯-1-甲基-2,... 616202-81-4 |
| 文献：ARENA PHARMACEUTICALS, INC. Patent: WO2005/42491 A1, 2005 ; Location in patent: Page/Page column 43 ; WO 2005/042491 A1 |
|
~%
(S)-8-氯-1-甲基-2,... 616202-81-4 |
| 文献：Smith, Brian M.; Smith, Jeffrey M.; Tsai, James H.; Schultz, Jeffrey A.; Gilson, Charles A.; Estrada, Scott A.; Chen, Rita R.; Park, Douglas M.; Prieto, Emily B.; Gallardo, Charlemagne S.; Sengupta, Dipanjan; Thomsen, William J.; Saldana, Hazel R.; Whelan, Kevin T.; Menzaghi, Frederique; Webb, Robert R.; Beeley, Nigel R.A. Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 5 p. 1467 - 1470 |
|
~%
(S)-8-氯-1-甲基-2,... 616202-81-4 |
| 文献：Smith, Brian M.; Smith, Jeffrey M.; Tsai, James H.; Schultz, Jeffrey A.; Gilson, Charles A.; Estrada, Scott A.; Chen, Rita R.; Park, Douglas M.; Prieto, Emily B.; Gallardo, Charlemagne S.; Sengupta, Dipanjan; Thomsen, William J.; Saldana, Hazel R.; Whelan, Kevin T.; Menzaghi, Frederique; Webb, Robert R.; Beeley, Nigel R.A. Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 5 p. 1467 - 1470 |
|
~%
(S)-8-氯-1-甲基-2,... 616202-81-4 |
| 文献：Smith, Brian M.; Smith, Jeffrey M.; Tsai, James H.; Schultz, Jeffrey A.; Gilson, Charles A.; Estrada, Scott A.; Chen, Rita R.; Park, Douglas M.; Prieto, Emily B.; Gallardo, Charlemagne S.; Sengupta, Dipanjan; Thomsen, William J.; Saldana, Hazel R.; Whelan, Kevin T.; Menzaghi, Frederique; Webb, Robert R.; Beeley, Nigel R.A. Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 5 p. 1467 - 1470 |
![2-CHLORO-N-[2-(4-CHLORO-PHENYL)-ETHYL]-PROPIONAMIDE结构式](https://image.chemsrc.com/caspic/259/34164-14-2.png)
![8-CHLORO-1-METHYL-4,5-DIHYDRO-1H-BENZO[D]AZEPIN-2(3H)-ONE结构式](https://image.chemsrc.com/caspic/458/824430-77-5.png)
| 1H-3-Benzazepine, 8-chloro-2,3,4,5-tetrahydro-1-methyl- |
| 1H-3-Benzazepine,8-chloro-2,3,4,5-tetrahydro-1-methyl-,(1S) |
| 8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine |
| 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
本网页内容来自不同专业数据源，如对内容有疑义，欢迎联系service1@chemsrc.com。
